社区成人血清MMP-7与呼吸道症状及死亡率的关系:MESA研究
在MESA队列1227名无呼吸道症状选择的社区成人中,基线血清MMP-7每增加一个自然对数单位,与FVC%绝对下降3.7%、劳力性呼吸困难 odds 增加1.6倍、ILA odds 增加1.5倍及全因死亡率增加2.2倍相关;ILA和死亡率关联在从不吸烟者中更强。
要点
- 血清MMP-7与FVC%下降、劳力性呼吸困难、ILA及全因死亡率独立相关。
- MMP-7可能作为社区成人亚临床肺细胞外基质重塑的定量生物标志物。
- ILA和死亡率关联在从不吸烟者中趋向更强。
核心结论
- 血清MMP-7水平可能是社区成人肺部亚临床细胞外基质重塑的定量生物标志物。
研究设计与样本
- 在MESA队列基线测量1227名社区成人的血清MMP-7,不按呼吸道症状或疾病选择。
- 5年结局数据:肺功能n=697、咳嗽n=722、呼吸困难n=1050;10年结局数据:ILA n=561、死亡率n=1227。
- 采用线性、逻辑和Cox回归控制潜在混杂因素。
主要发现
- 血清MMP-7均值(±SD)为4.3(±2.5)ng/ml,范围1.2-24.1 ng/ml。
- 校正模型中,血清MMP-7每增加一个自然对数单位,FVC%绝对下降3.7%(95%CI=0.9-6.6%)。
- 劳力性呼吸困难 odds 增加1.6倍(95%CI=1.3-1.9),ILA odds 增加1.5倍(95%CI=1.1-2.1),全因死亡率增加2.2倍(95%CI=1.9-2.5)。
- ILA和死亡率关联在从不吸烟者中趋向更强(交互作用P值分别为0.06和0.01)。
临床怎么用
- 在社区成人中,血清MMP-7升高提示亚临床肺细胞外基质重塑可能,需关注肺功能、呼吸症状及ILA。
- MMP-7可能有助于亚临床间质性肺疾病的研究与早期识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Matrix metalloproteinase-7 (MMP-7) has been implicated in interstitial lung disease pathobiology and proposed as a diagnostic and prognostic biomarker of idiopathic pulmonary fibrosis. OBJECTIVES: To test associations between serum MMP-7 and lung function, respiratory symptoms, interstitial lung abnormalities (ILA), and all-cause mortality in community-dwelling adults sampled without regard to respiratory symptoms or disease. METHODS: We measured serum MMP-7 in 1,227 participants in MESA (Multi-Ethnic Study of Atherosclerosis) at baseline. The 5-year outcome data were available for spirometry (n = 697), cough (n = 722), and dyspnea (n = 1,050). The 10-year outcome data were available for ILA (n = 561) and mortality (n = 1,227). We used linear, logistic, and Cox regression to control for potential confounders. MEASUREMENTS AND MAIN RESULTS: The mean (±SD) serum MMP-7 level was 4.3 (±2.5) ng/ml (range, 1.2-24.1 ng/ml). In adjusted models, each natural log unit increment in serum MMP-7 was associated with a 3.7% absolute decrement in FVC% (95% confidence interval [CI] = 0.9-6.6%), a 1.6-fold increased odds of exertional dyspnea (95% CI = 1.3-1.9), a 1.5-fold increased odds of ILAs (95% CI = 1.1-2.1), and a 2.2-fold increased all-cause mortality rate (95% CI = 1.9-2.5). The associations with ILA and mortality tended to be stronger among never-smokers (P values for interaction 0.06 and 0.01, respectively). CONCLUSIONS: Serum MMP-7 levels may be a quantitative biomarker of subclinical extracellular matrix remodeling in the lungs of community-dwelling adults, which may facilitate investigation of subclinical interstitial lung disease.
引用
- Armstrong HF, Podolanczuk AJ, Barr RG, et al. Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis). Am J Respir Crit Care Med. 2017. PMID: 28570100. doi:10.1164/rccm.201701-0254OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。